.ANALYSIS EMPHASIZE.06 August 2024.
A sizable randomized regulated trial along with cisgender ladies highlights the problems of faithfulness to a daily oral preexposure prevention regiment as well as illustrates that twice-yearly shot of lenacapavir can maintain successful HIV protection levels over 6 months.